TrialJournal of neuro-oncology2011

Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.

David A Reardon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.